In the SURPASS-4 trial, adults with T2DM at heightened cardiovascular risk, who were inadequately managed with oral glucose-lowering agents, once-weekly tirzepatide (5 mg, 10 mg, or 15 mg) were compared to insulin glargine (100 U/mL)
Transl Res (2021) 227:7588
The review cautions that effective dosing, duration, and efficacy for non-metabolic and neuropsychiatric indications, including Alzheimers disease and substance use disorders, remain to be established
Many patients ask about Ozempic face because appearance is often part of the motivation for losing weight in the first place
These results show that GLP-1 might act directly through the GPI/IPG-coupled receptor on osteoblastic MC3T3-E1 cells
If youre still falling short of your protein target, talk to your Weight Watchers Clinician or Registered Dietitian about adding a protein supplement